NCT07134387

Brief Summary

The objective of this study is to examine the long-term impact of having a child with Bronchopulmonary Dysplasia (BPD) on the parents and caregivers from the time of diagnosis through adulthood. The primary focus will be on parents and caregivers of children until the age of 18 (\< 18) years who were diagnosed with BPD as newborns. Data will be collected through an online questionnaire in France, Germany, Italy, the Netherlands, Spain, the United Kingdom (including Northern Ireland), and the United States. It will ask about inclusion and exclusion criteria, background information (caregiver, child, and family situation), the child's medical situation, parental health-related quality of life (HRQoL), health literacy, feelings, support structures, and economic burden of the family.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
480

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Sep 2025Jan 2027

First Submitted

Initial submission to the registry

August 14, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 21, 2025

Completed
26 days until next milestone

Study Start

First participant enrolled

September 16, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Expected
Last Updated

November 21, 2025

Status Verified

November 1, 2025

Enrollment Period

5 months

First QC Date

August 14, 2025

Last Update Submit

November 18, 2025

Conditions

Keywords

Parental Quality of lifeQoLHealth-related quality of lifeHRQoLCaregiver burdenParental well-beingFamilyBronchopulmonary Dysplasia (BPD)Chronic Lung Disease (CLD)Chronic Lung Diseaseof NewbornRespiratory MorbidityLong-term outcomesParentsCaregiversInfantsNewbornChildrenPretermPrematurityNICUIntensive CareNeonatalSurveyQuestionnaireMultinational studyretrospective data collectionparticipatory researchPatient-reported outcomesPROsPatient-reported outcome measuresPROMs

Outcome Measures

Primary Outcomes (1)

  • Parental health-related quality of life (HRQoL) assesed by Pediatric Quality of Life Inventory, Family Impact Module (PedsQL FIM)

    To record the parents' HRQoL, the Pediatric Quality of Life Inventory Family Impact Module (PedsQL FIM) is implemented, a validated and widely used instrument designed to measure the impact of pediatric acute and chronic health conditions on parents and the family. It consists of 36 items across six parental dimensions (physical, emotional, social, and cognitive functioning, communication, and worry), as well as family daily activities and relationships. It is validated in all official languages of the seven participating countries (English, French, German, Italian, Dutch, Spanish) and allows the calculation of a sum score.

    09/2025 - 02/2026

Secondary Outcomes (5)

  • Participant characteristics assesed by self developed online questionnaire

    09/2025 - 02/2026

  • Medical Situation of the child assesed by self developed online questionnaire (parent report)

    09/2025 - 02/2026

  • Economic burden on families (Quantitative and qualitative) assesed by adapted version of the Family Economic Impact Inventory (Domain Family Finances)

    09/2025 - 02/2026

  • Health Literacy (Quantitative) assesed by self-developed online questionnaire

    09/2025 - 02/2026

  • Support Structures (Quantitative and qualitative) assesed by self developed online questionnaire

    09/2025 - 02/2026

Study Arms (2)

Parents or caregivers of children with (a history of) physician diagnosed BPD

The primary population of this study consists of parents and caregivers of preterm born children (\< 37 weeks of gestation) under 18 years old who have been diagnosed with newborn-onset Bronchopulmonary Dysplasia (BPD). Furthermore, the child should have been discharged from their initial hospital stay after birth. Participants will be recruited from multiple countries, including France, Germany, Italy, the Netherlands, Spain, the United Kingdom (including Northern Ireland), and the United States.

Other: N/A, no intervention, participation in survey

Parents or caregivers of preterm born children without chronic health conditions

The control group consists of parents and caregivers of preterm born children (\< 37 weeks of gestation) under 18 years old who do not report a history of BPD. Furthermore, the child should have been discharged from their initial hospital stay after birth. They will as well be recruited from France, Germany, Italy, the Netherlands, Spain, the United Kingdom (including Northern Ireland), and the United States. If the final sample size permits, a post hoc filter will be applied to restrict analyses to the subgroup of very preterm (\< 32 weeks gestation) and/or very low birthweight (\< 1500 g birthweight) children.

Other: N/A, no intervention, participation in survey

Interventions

A unified questionnaire will be utilized for all participants, irrespective of their group assignment. Participants will be assigned to the BPD or comparison group retrospectively, based on their answers defining the BPD-status. To enhance comprehension, the questionnaire avoids using the term "BPD" wherever feasible and instead employs a more general reference to lung problems.

Parents or caregivers of children with (a history of) physician diagnosed BPDParents or caregivers of preterm born children without chronic health conditions

Eligibility Criteria

Age0 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of parents and caregivers of preterm-born children under 18 years old who have already been discharged from their initial hospital stay. Participants will be recruited from multiple countries, including France, Germany, Italy, the Netherlands, Spain, the United Kingdom/Northern Ireland, and the United States. They will be assigned to the BPD or comparison group retrospectively, based on their answers defining the BPD-status.

You may qualify if:

  • BPD-group:
  • Being a parent or primary caregiver of a child until the age of 18 years (0 to under 18 years),
  • who was born preterm (before 37 weeks of gestation),
  • who has been discharged from their initial hospital stay after birth,
  • who suffered from BPD in the newborn period and
  • who was born or is currently living in the following countries: France, Germany, Italy, the Netherlands, Spain, the United Kingdom (including Northern Ireland) and the United States
  • providing sufficient proficiency in one of the languages of the questionnaire
  • Control group:
  • Being a parent or primary caregiver of a child until the age of 18 years (0 to under 18 years),
  • who was born preterm (before 37 weeks of gestation),
  • who has been discharged from their initial hospital stay after birth,
  • who did not suffer from BPD in the newborn period and
  • who was born or is currently living in the following countries: France, Germany, Italy, the Netherlands, Spain, the United Kingdom (including Northern Ireland) and the United States
  • providing sufficient proficiency in one of the languages of the questionnaire

You may not qualify if:

  • BPD-group:
  • Other family members than parents/primary caregivers
  • Parents or primary caregivers
  • of a child older/equal than 18 years of age
  • of a child with BPD who has not been discharged yet
  • of a child without a BPD in the newborn period
  • with insufficient proficiency in one of the languages available in the questionnaire
  • Control group:
  • Other family members than parents/primary caregivers
  • Parents or primary caregivers
  • of children older/equal than 18 years of age
  • of a child born term
  • of a child without BPD who has not been discharged yet
  • with insufficient proficiency in one of the languages available in the questionnaire

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Global Foundation for the Care of Newborn Infants (GFCNI)

München, Bavaria, 81379, Germany

RECRUITING

MeSH Terms

Conditions

Bronchopulmonary DysplasiaCaregiver BurdenPremature Birth

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Ventilator-Induced Lung InjuryLung InjuryLung DiseasesRespiratory Tract DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesStress, PsychologicalBehavioral SymptomsBehaviorObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Julia Feiler, Dr

    Global Foundation for the Care of Newborn Infants (GFCNI)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Christina Tischer, Dr

CONTACT

Julia Feiler, Dr

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 14, 2025

First Posted

August 21, 2025

Study Start

September 16, 2025

Primary Completion

February 1, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

November 21, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations